Outcome Capital LLC has expanded its biotech practice with the addition of Ellen Baron to its executive team.
Baron most recently was a managing director of biopharmaceuticals at Healthios Capital Markets LLC.
Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.
At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.
Outcome Capital adds to biotech practice
Street Talk Episode 68 - As many investors zig away from bank stocks, 2 vets in the space zag toward them
Street Talk Episode 66 - Community banks tap the debt markets while the getting is good
Street Talk Episode 67 - Veteran investor tabs Mick Mulvaney to help with latest financial stock-focused fund
Street Talk Episode 65 - Deferral practices trap US bank portfolios in purgatory